<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 5 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Trebuchet MS";
panose-1:2 11 6 3 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
span.DefaultFontHxMailStyle
{mso-style-name:"Default Font HxMail Style";
font-family:"Arial",sans-serif;
color:windowtext;
font-weight:normal;
font-style:normal;
text-decoration:none none;}
span.org
{mso-style-name:org;}
span.locality
{mso-style-name:locality;}
span.region
{mso-style-name:region;}
span.postal-code
{mso-style-name:postal-code;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style></head><body lang=EN-CA link=blue vlink="#954F72" style='word-wrap:break-word'><div class=WordSection1><p class=MsoNormal><span class=DefaultFontHxMailStyle>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>See below for many links to interesting articles.<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>Take care & stay well.<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle>Glen<o:p></o:p></span></p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><p class=MsoNormal>Sent from <a href="https://go.microsoft.com/fwlink/?LinkId=550986">Mail</a> for Windows</p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><div style='mso-element:para-border-div;border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0cm 0cm 0cm'><p class=MsoNormal style='border:none;padding:0cm'><b>From: </b><a href="mailto:prostatepedia@naspcc.org">Prostatepedia</a><br><br><b>Subject: </b>Prostatepedia Digest 1.28.2022</p></div><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;background:#FAFAFA;border-collapse:collapse'><tr><td width="100%" valign=top style='width:100.0%;padding:7.5pt 7.5pt 7.5pt 7.5pt'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width=600 style='width:450.0pt;border-collapse:collapse'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='max-width:450.0pt;border-collapse:collapse'><tr><td valign=top style='background:#FAFAFA;padding:6.75pt 0cm 6.75pt 0cm'></td></tr><tr><td valign=top style='background:white;padding:6.75pt 0cm 0cm 0cm;background:cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-size: cover;background-position-x:50%;background-position-y:50%' id=templateHeader><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=e39345528f&e=80a893c0a5" target="_blank"><strong><span style='font-size:18.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:red'>Sign up for Prostatepedia's Free Publications</span></strong></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td></tr><tr><td valign=top style='border:none;border-bottom:solid #EAEAEA 1.5pt;background:white;padding:0cm 0cm 6.75pt 0cm;background:cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-size: cover;background-position-x:50%;background-position-y:50%' id=templateBody><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><img border=0 width=564 height=162 style='width:5.875in;height:1.6875in' id="_x0000_i1030" src="https://mcusercontent.com/9154133f2e98aca1db87520cb/images/d701134e-9eff-4181-a839-0b935f4b3420.jpg"><o:p></o:p></p></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #EAEAEA 4.5pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:13.5pt 13.5pt 13.5pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #EAEAEA 1.5pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:150%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br></span><strong><span style='font-size:24.0pt;line-height:150%;font-family:"Trebuchet MS",sans-serif;color:#202020'>New Links and Resources.</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br></span><span style='font-size:13.5pt;line-height:150%;font-family:"Arial",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=c167c10f9c&e=80a893c0a5"><span style='color:#007C89'>Prostatepedia's December 2021 Issue on Immuno-Oncology and Chemotherapy</span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br>Treatments driving a new Resistant Mutational Phenotype of Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=8c1b79b48d&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Do Our Treatments Drive a New Resistant Mutational Phenotype? - Ana Aparicio</span></a><br><br>ADT with Definitive Radiotherapy in Localized Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=34c3d44513&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Androgen Deprivation Therapy Use and Duration with Definitive Radiotherapy for Localised Prostate Cancer: An Individual Patient Data Meta-Analysis</span></a><br><br>Racial and Ethnic Disparities in Care: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=4b229befac&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Racial/ethnic disparities in patient experiences with care and Gleason score at diagnosis of prostate cancer: a SEER-CAHPS study.</span></a><br><br>Acquired Resistance to Irradiation or Docetaxel: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=39e73fdd6c&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines.</span></a><br><br>Combination Therapy for mCRPC: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=fc48d115b8&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Combination therapy for mCRPC with immune checkpoint inhibitors, ADT and vaccine: A mathematical model.</span></a><br><br>Same-Day Discharge after Robotic Prostatectomy: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=721277af05&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Same-day-discharge Robot-assisted Radical Prostatectomy: An Annual Countrywide Analysis.</span></a><br><br>A new antibody-drug conjugate, MGC018, in mCRPC: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=f5fdfd859d&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Preliminary Results of MGC018, an anti B7-H3 Antibody Drug Conjugate in mCRPC – Eugene Shenderov</span></a><br><br>Germline DNA Damage Repair Alterations in Patients with Localized Prostate Cancer treated with Neoadjuvant ADT: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=7068df363c&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Germline DNA Damage Repair Alterations in Patients with Localized Prostate Cancer Treated with Neoadjuvant Androgen Deprivation Therapy - Expert Commentary</span></a><br><br>CONTACT -02 Study of cabozantinib plus atezolizumab versus second novel hormone therapy in mCRPC:<a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=fdb43b6cad&e=80a893c0a5" target="_blank"><span style='color:#007C89'> A Phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.</span></a><br><br>T2 Mapping MRI for Prostate Cancer Detection and Classification: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=f2a2df0076&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Value of T2 Mapping MRI for Prostate Cancer Detection and Classification.</span></a><br><br>Video: Best Patient Selection for Radium-223 in mCRPC: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=f342476a78&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Optimal Patient Selection for Treatment with Radium-223 in mCRPC Towards Improved Overall Survival and Improved Quality of Life - Brenda Martone</span></a><br><br>Video: Pain efficacy of Radium-223 in mCRPC Patients with Symptomatic Bone Metastases: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=b867587173&e=80a893c0a5" target="_blank"><span style='color:#007C89'>A Real-World Analysis of Pain Efficacy of Radium-223 Treatment Among Patients With Metastatic Castration-Resistant Prostate Cancer and Symptomatic Bone Metastases – the REASSURE Trial – Celestia Higano</span></a><br><br>Video: Bone-Protecting Agents in mCRPC: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=5b671ca892&e=80a893c0a5" target="_blank"><span style='color:#007C89'>The Importance of Bone-Protecting Agents When Treating mCRPC with Bone Metastatic Disease The PEACE III Trial – Silke Gillessen</span></a><br><br>Radioligand Therapy within 3 months of Radium-223: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=48d25f23e9&e=80a893c0a5" target="_blank"><span style='color:#007C89'>SNMMI 2021: Safety and Efficacy of Radioligand Therapy with 177lutetium-PSMA-617 Within 3 Months After 223Radium-Dichloride</span></a><br><br>Characterizing Bone Lesions with PET/CT: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=9885f54b04&e=80a893c0a5" target="_blank"><span style='color:#007C89'>SNMMI 2021: Characterizing Bone Lesions in Prostate Cancer Patients with PET/CT Imaging</span></a><br><br>Prostate MRI Predicts Continence after Radical Prostatectomy: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=c52240d9c8&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Prostate MRI predicts urinary continence after surgery</span></a><br><br>Depression and Newer Hormone Agents in Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=82bb3de6fd&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression</span></a><br><br>Risk Stratification of Localized Disease: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=77bd3838d9&e=80a893c0a5" target="_blank"><span style='color:#007C89'>ESOU 2022: State-of-the-art Lecture: Molecular Advances in Risk Stratification of Localized Prostate Cancer</span></a><br><br>Neoadjuvant Treatments Before Radical Prostatectomy: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=e97f72ec17&e=80a893c0a5" target="_blank"><span style='color:#007C89'>ESOU 2022: Neoadjuvant Treatments before Radical Prostatectomy for High-Risk Prostate Cancer: Developments and Challenges</span></a><br><br>BiTE Mechanism (Immuno-Oncology) in Development for Advanced Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=d2d148cb14&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Bispecific T-cell Engager (BiTE®) in Development for Treatment of Advanced Prostate Cancer - Oliver Sartor</span></a><br><br>Imaging: Reading and Reporting Results of a PSMA PET/CT for Staging Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=cd03358573&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Reading and Reporting a PSMA PET Scan for Staging Prostate Cancer - Andrea Farolfi</span></a><br><br>Should a TRUS-Guided Biopsy Remain Standard of Care?: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=ee32da93f6&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer.</span></a><br><br>Active Surveillance for Intermediate-Risk Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=78fe4922e5&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Active surveillance for intermediate-risk prostate cancer.</span></a><br><br>PSA Screening in the US According to Health Professional Counseling and Age, since the last set of USPSTF Recommendations: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=309e5b6a9e&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Prostate-Specific Antigen Screening According to Health Professional Counseling and Age in the United States.</span></a><br><br>Supportive Care Needs for Men with Prostate Cancer: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=da6055b9dc&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Supportive care needs of men with prostate cancer: A systematic review update.</span></a><br><br>Video: 2022 NCNN Guidelines for Localized Disease: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=e06382ea76&e=80a893c0a5" target="_blank"><span style='color:#007C89'>NCCN Guidelines 2022 - Prostate Cancer on Comparison of Treatment Options for Localized Disease + Local Therapies + Disease Monitoring - Zachary Klaassen and Chris Wallis</span></a><br><br>Video: 2022 NCCN Guidelines on Staging Evaluation and Imaging: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=dc888d4a7b&e=80a893c0a5" target="_blank"><span style='color:#007C89'>NCCN Guidelines - Staging Evaluation and Imaging Approaches in Prostate Cancer – Christopher Wallis and Zachary Klaassen</span></a><br><br>Video: 2022 NCCN Guidelines on Advanced Prostate Cancer including Neuroendocrine Disease: <a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=2eb779b5bb&e=80a893c0a5" target="_blank"><span style='color:#007C89'>NCCN Guidelines on Prostate Cancer Reviewing Advanced Prostate Cancer Neuroendocrine Disease, Bone and Visceral Metastases, and Treatment Sequencing – Christopher Wallis & Zachary Klaassen</span></a> </span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal style='line-height:150%'><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br></span><strong><span style='font-size:24.0pt;line-height:150%;font-family:"Trebuchet MS",sans-serif;color:#202020'>Reminders.</span></strong><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br></span><span style='font-size:13.5pt;line-height:150%;font-family:"Arial",sans-serif;color:#202020'>The 16<sup>th</sup> Annual Meeting of the National Alliance of State Prostate Cancer Coalitions (NASPCC) will take place on a new date: January 28-30, 2022. </span><span style='font-size:13.5pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=63b610d207&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Here is the Final Agenda</span></a>.</span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br></span><span style='font-size:13.5pt;line-height:150%;font-family:"Arial",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=ce53e90427&e=80a893c0a5"><span style='color:#007C89'>Please join NASPCC for a Webinar entitled “Overview of Prostate Cancer Imaging” With Thomas Hope, MD, Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco on Monday, February 7, 2022.</span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br></span><span style='font-size:13.5pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=b802425de1&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Merel Grey, president of NASPCC and Cal Ripken, Jr. Talk Prostate Cancer</span></a> <br><br><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=ca54a7b4aa&e=80a893c0a5" target="_blank"><span style='color:#007C89'>Jessie Myers-Schecter talks about her father, Snuffy Myers, and what it was like to be the daughter of a prostate cancer patient. </span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><br><br></span><span style='font-size:13.5pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=d1a0c8f00c&e=80a893c0a5" target="_blank"><span style='color:#007C89'>NASPCC and CancerCare Online Prostate Cancer Patient Support Group</span></a><br><br><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=5b159497b6&e=80a893c0a5" target="_blank"><span style='color:#007C89'>NASPCC Webinar Recordings Archive</span></a></span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'> </span><span style='font-size:12.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#202020'><o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 6.75pt 0cm 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><img border=0 width=564 height=436 style='width:5.875in;height:4.5416in' id="_x0000_i1029" src="https://mcusercontent.com/9154133f2e98aca1db87520cb/images/53731a5c-5b34-46de-a306-157337f67b36.jpg"><o:p></o:p></p></td></tr></table></td></tr></table></td></tr><tr><td valign=top style='background:#FAFAFA;padding:6.75pt 0cm 6.75pt 0cm;background:cover;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;background-size: cover;background-position-x:50%;background-position-y:50%' id=templateFooter><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 6.75pt 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:0cm 6.75pt 0cm 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 6.75pt 0cm 6.75pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><div align=center><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 7.5pt 6.75pt 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=24 style='width:18.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=b117a91179&e=80a893c0a5" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 style='width:.25in;height:.25in' id="_x0000_i1028" src="https://cdn-images.mailchimp.com/icons/social-block-v2/color-twitter-48.png" alt=Twitter></span></a><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 7.5pt 6.75pt 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=24 style='width:18.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=9c82b86dee&e=80a893c0a5" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 style='width:.25in;height:.25in' id="_x0000_i1027" src="https://cdn-images.mailchimp.com/icons/social-block-v2/color-facebook-48.png" alt=Facebook></span></a><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td><td valign=top style='padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left style='border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:0cm 0cm 6.75pt 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:3.75pt 7.5pt 3.75pt 6.75pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width=0 style='width:0cm;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=24 style='width:18.0pt;padding:0cm 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><p class=MsoNormal align=center style='text-align:center'><a href="https://naspcc.us17.list-manage.com/track/click?u=9154133f2e98aca1db87520cb&id=0f018892a8&e=80a893c0a5" target="_blank"><span style='text-decoration:none'><img border=0 width=24 height=24 style='width:.25in;height:.25in' id="_x0000_i1026" src="https://cdn-images.mailchimp.com/icons/social-block-v2/color-link-48.png" alt=Website></span></a><o:p></o:p></p></td></tr></table></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr></table></div></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='padding:7.5pt 13.5pt 18.75pt 13.5pt;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;border:none;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td style='border:none;border-top:solid #EEEEEE 1.5pt;padding:0cm 0cm 0cm 0cm;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'></td></tr></table></td></tr></table><p class=MsoNormal><span style='display:none'><o:p> </o:p></span></p><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;border-collapse:collapse;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td valign=top style='padding:6.75pt 0cm 0cm 0cm;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;margin-left:-2.25pt;margin-right:-2.25pt;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><tr><td width=600 valign=top style='width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width: 100%;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%'><table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0 align=left width="100%" style='width:100.0%;border-collapse:collapse;-ms-text-size-adjust: 100%;-webkit-text-size-adjust: 100%;word-break:break-word'><tr><td valign=top style='padding:0cm 13.5pt 6.75pt 13.5pt'><p class=MsoNormal align=center style='text-align:center;line-height:150%'><em><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'>Copyright © 2022 Prostatepedia NASPCC, All rights reserved.</span></em><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'> <br>You are receiving this email because you opted in via our website. <br><br><strong><span style='font-family:"Helvetica",sans-serif'>Our mailing address is:</span></strong> </span><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'><o:p></o:p></span></p><div><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span class=org><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'>Prostatepedia NASPCC</span></span><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'><o:p></o:p></span></p><div><div><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'>1999 Avenue of the Stars Ste 1100<o:p></o:p></span></p></div><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span class=locality><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'>Los Angeles</span></span><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'>, <span class=region>CA</span> <span class=postal-code>90067-4618</span><o:p></o:p></span></p></div><p class=MsoNormal align=center style='text-align:center;line-height:150%'><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'><br><a href="https://naspcc.us17.list-manage.com/vcard?u=9154133f2e98aca1db87520cb&id=c67ed256e6"><span style='color:#656565'>Add us to your address book</span></a><o:p></o:p></span></p></div><p class=MsoNormal align=center style='margin-bottom:12.0pt;text-align:center;line-height:150%'><span style='font-size:9.0pt;line-height:150%;font-family:"Helvetica",sans-serif;color:#656565'><br><br>. <o:p></o:p></span></p></td></tr></table></td></tr></table></td></tr></table></td></tr></table></div></td></tr></table></div></td></tr></table></div><p class=MsoNormal><img border=0 width=1 height=1 style='width:.0104in;height:.0104in' id="_x0000_i1025" src="https://naspcc.us17.list-manage.com/track/open.php?u=9154133f2e98aca1db87520cb&id=dabd26be7d&e=80a893c0a5"><o:p></o:p></p><p class=MsoNormal><span class=DefaultFontHxMailStyle><o:p> </o:p></span></p></div></body></html>